In a surprise departure, Alnylam's founding CEO John Maraganore is leaving the company — shares crater
John Maraganore, the determined Alnylam CEO who led the company through thick and thin to help birth the RNAi revolution, is on his way out of the executive suite.
In a surprise announcement Thursday morning, Maraganore said that he will hand the reins to current president Yvonne Greenstreet at the end of the year, marking the end of a 20-year run as the founding CEO of the storied company. He will stay on through the first quarter as a consultant and will take a seat on Alnylam’s scientific advisory board.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 154,000+ biopharma pros reading Endpoints daily — and it's free.